USD 11.35
(-0.44%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | - USD | 57.74% |
2022 | - USD | -10266.96% |
2021 | - USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -314.96 Thousand USD | -20.46% |
2024 Q2 | -239.04 Thousand USD | 22.17% |
2023 Q4 | -244.06 Thousand USD | -32.23% |
2023 FY | - USD | 57.74% |
2023 Q3 | -184.57 Thousand USD | 59.52% |
2023 Q1 | -358.88 Thousand USD | 63.84% |
2023 Q2 | -455.96 Thousand USD | -27.05% |
2022 Q1 | -296.89 Thousand USD | -905.22% |
2022 Q4 | -992.47 Thousand USD | -422.28% |
2022 FY | - USD | -10266.96% |
2022 Q3 | 307.95 Thousand USD | 152.73% |
2022 Q2 | -583.99 Thousand USD | -96.7% |
2021 Q4 | -29.53 Thousand USD | -425.72% |
2021 FY | - USD | 0.0% |
2021 Q2 | -1994.00 USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q3 | -5618.00 USD | -181.75% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Ault Disruptive Technologies Corporation | - USD | NaN% |
HNR Acquisition Corp | 4.96 Billion USD | 100.0% |
HNR Acquisition Corp | 4.96 Billion USD | 100.0% |
Unusual Machines, Inc. | -2.37 Million USD | 100.0% |
Viveon Health Acquisition Corp. | 1.94 Million USD | 100.0% |